Latest Revenue Growth News

Findi Limited updates FY26 guidance with over A$100 million revenue forecast, announces acquisition of Sphere loyalty platform, and advances IPO plans on Bombay Stock Exchange.

Findi Limited has arranged a new A$30 million debt facility and agreed to acquire Sphere, enhancing its digital payments ecosystem ahead of a planned FY27 Indian IPO. Despite short-term challenges, the company projects strong revenue growth and operational momentum in FY26.

Qoria Limited reported a strong start to FY2026, with annual recurring revenue climbing 25% year-on-year and record cash receipts of $46.3 million, prompting an upgrade to its full-year revenue guidance.

Mesoblast Limited reports a 69% jump in net revenues from its pioneering cell therapy Ryoncil in Q1 FY2026, propelled by expanded physician adoption and new reimbursement pathways. The company also secures convertible note funding and plans pivotal adult trials.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

DroneShield Limited has delivered a blockbuster quarter with record revenue and operating cash flow, driven by new SaaS products and major government contracts. The company is positioning itself for sustained profitability and expansion into civilian markets.

Botanix Pharmaceuticals reports a strong start to FY26 with a 50% surge in Sofdra prescriptions and a 65% rise in net revenue, underpinned by a larger sales team and operational efficiencies.

Vection Technologies has secured $1.5 million in AI-driven enterprise orders spanning agritech, cybersecurity, real estate, healthcare, and public administration, reinforcing its recurring revenue model and cross-sector appeal.

PARKD Limited has successfully closed its Share Purchase Plan, raising $220,000; well above the initial $120,000 target; following a recent $780,000 placement. This capital boost underscores strong shareholder confidence in the company’s innovative building solutions.

De.mem Limited has acquired Core Chemicals Pty Ltd for $2.68 million, nearly doubling its EBITDA and positioning itself to capitalise on a surging gold sector. The deal combines strong recurring revenues with significant synergy potential.

XRF Scientific has reported a robust September quarter with a 16% increase in revenue, driven by strong international sales and new product launches. The company is poised for further expansion with ongoing innovation and strategic focus on global markets.

Saunders International has landed a $19.8 million contract to build 11 tanks at a gold processing facility, reinforcing its foothold in the resources sector and promising revenue growth over the next two years.